![Severe Group A Streptococcal Infections Associated with a Toxic Shock-like Syndrome and Scarlet Fever Toxin A | NEJM Severe Group A Streptococcal Infections Associated with a Toxic Shock-like Syndrome and Scarlet Fever Toxin A | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1989/nejm_1989.321.issue-1/nejm198907063210101/20130822/images/img_medium/nejm198907063210101_t1.jpeg)
Severe Group A Streptococcal Infections Associated with a Toxic Shock-like Syndrome and Scarlet Fever Toxin A | NEJM
![Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial - The Lancet Infectious Diseases Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/91d7749a-4616-4c53-b903-ac2f493085ff/gr1_lrg.jpg)
Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial - The Lancet Infectious Diseases
![Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial - The Lancet Infectious Diseases Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/57571ce1-b8d5-4336-a691-63438d0366c7/gr1.gif)
Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial - The Lancet Infectious Diseases
![Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus | Clinical Microbiology Reviews Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus | Clinical Microbiology Reviews](https://journals.asm.org/cms/10.1128/cmr.00101-13/asset/46982b18-0370-4e56-a9a1-86e603fd50cf/assets/graphic/zcm9990924580001.jpeg)
Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus | Clinical Microbiology Reviews
![Study: Breast Milk Oligosaccharides Kill Group B-Streptococcus, Block Biofilm Formation | Medicine | Sci-News.com Study: Breast Milk Oligosaccharides Kill Group B-Streptococcus, Block Biofilm Formation | Medicine | Sci-News.com](https://cdn.sci.news/images/enlarge4/image_5148e-Group-B-Streptococcus.jpg)
Study: Breast Milk Oligosaccharides Kill Group B-Streptococcus, Block Biofilm Formation | Medicine | Sci-News.com
![Group A streptococcal infections can cause strep throat, scarlet fever, or skin infections such as impetigo. Most cases are mild, but a small proportion of children can develop an invasive infection where Group A streptococcal infections can cause strep throat, scarlet fever, or skin infections such as impetigo. Most cases are mild, but a small proportion of children can develop an invasive infection where](https://assets.practice365.co.uk/wp-content/uploads/sites/741/2022/12/Strep-A-GP-Post-05.12.2022-1024x1024.jpg)